Siemens Healthineers AG (LTS:0PMJ) Revenue: €23,168 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0PMJ Siemens Healthineers AG LTS:0PMJ
85 GF Score
Price €39.10
GF Value €51.00
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Siemens Healthineers AG Revenue?

Siemens Healthineers AG LTS:0PMJ -0.36% 85 Revenue is €23,168 Mil as of Jun. 2026. GuruFocus rates LTS:0PMJ with a GF Score™ of 85/100 and a GF Value™ of €51.00 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Siemens Healthineers AG's revenue for the three months ended in Jun. 2026 was €5,764 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was €23,168 Mil. Siemens Healthineers AG's Revenue per Share for the three months ended in Jun. 2026 was €5.17. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was €20.62.

Warning Sign:

Siemens Healthineers AG revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Siemens Healthineers AG was -0.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 2.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 7.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was 5.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 11 years, Siemens Healthineers AG's highest 3-Year average Revenue per Share Growth Rate was 10.20% per year. The lowest was 1.30% per year. And the median was 4.65% per year.


Siemens Healthineers AG  (LTS:0PMJ) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Siemens Healthineers AG Revenue Related Terms


Siemens Healthineers AG Revenue Historical Data

* Premium members only.

The historical data trend for Siemens Healthineers AG's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Siemens Healthineers AG Revenue Chart

Siemens Healthineers AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17,997.00 21,714.00 21,680.00 22,363.00 23,375.00

Siemens Healthineers AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,662.00 6,322.00 5,402.00 5,680.00 5,764.00

LTS:0PMJ vs ABT, SYK, MDT: Revenue Comparison

For the Medical Devices subindustry, Siemens Healthineers AG's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siemens Healthineers AG Revenue vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's Revenue distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's Revenue falls into.


LTS:0PMJ
85GF Score
Siemens Healthineers AG LTS:0PMJ
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Siemens Healthineers AG Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €23,168 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of €23,168 Mil mean?
Siemens Healthineers AG (LTS:0PMJ) has a Revenue of €23,168 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Siemens Healthineers AG and its competitors.
Is Siemens Healthineers AG's Revenue too high?
Siemens Healthineers AG's current Revenue is €23,168 Mil. Overall, Siemens Healthineers AG has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siemens Healthineers AG's Revenue compare to ABT and SYK?
Siemens Healthineers AG's Revenue of €23,168 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Siemens Healthineers AG and its competitors. Siemens Healthineers AG's current Revenue is €23,168 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siemens Healthineers AG stock overvalued right now?
Based on GuruFocus' analysis, Siemens Healthineers AG (LTS:0PMJ) is currently considered Modestly Undervalued. The stock's GF Value™ is €51.00, compared to a current price of €39.10 — trading 23.3% below its estimated fair value. The current Revenue is €23,168 Mil. Siemens Healthineers AG's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Siemens Healthineers AG (LTS:0PMJ), the current Revenue is €23,168 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Siemens Healthineers AG (LTS:0PMJ) Overvalued in 2026?

Based on GuruFocus' analysis, Siemens Healthineers AG stock appears to be undervalued. The current stock price of €39.10 is trading 23.3% below its estimated GF Value™ of €51.00. GuruFocus considers Siemens Healthineers AG to be Modestly Undervalued.

Key valuation signals for LTS:0PMJ:

  • Revenue: €23,168 Mil
  • GF Value™: €51.00 vs. price of €39.10 (23.3% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the LTS:0PMJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Siemens Healthineers AG Business Description

Address Siemensstrasse 3, Forchheim, BY, DEU, 91301
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
85GF Score

Get the complete analysis for LTS:0PMJ

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€39.10
Price
€51.00
GF Value